TrialBlood cancer journal2017

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

M Hunault-Berger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.